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ABSTRACT 
A maximum likelihood factor analysis (MLFA) of the 
dynamics of the human immune system in malaria, 
based on the observation of a few cytokine in plasma, 
suggests that an increased overproduction of cytokines: 
IL-12, IL-6, IFN-γ, IL-2, and IL-5, over the cytokines: 
TGF-β,  TNF-α, IL-10 and IL-1β has protective effects 
against severe malaria and cerebral malaria.  
According to a simplified model of the human adap-
tive immunity and the MLFA results, basal levels of cy-
tokine IL-6 may play a key role in the favorable resolu-
tion of a malaria infection.  
1. INTRODUCTION 
In spite of the research efforts made in the fight against 
malaria, we are far from achieving an effective vaccine 
[1]. A possible explanation to this fact would be the 
partial knowledge of how natural malaria immunity is 
acquired in humans. The residents of regions where ma-
laria is endemic, develop some form of natural partial 
immunity that maintains asymptomatic even if they are 
parasite carriers. The speed and intensity that the immu-
nological system responds to malaria infection is deter-
mining for a favorable outcome of the infection [2].  
A usual way of characterizing the dynamics of the 
immunological human system is based on the observa-
tion and analysis of certain variables, such as the cyto-
kine concentration in plasma. Given that the number of 
cytokines to measure can be very large, which cytokines 
are relevant for correctly characterizing the dynamics of 
the immunological human system in malaria? 
2. CYTOKINES ANALYSIS IN MALARIA 
A usual way to answer this question in dynamic systems 
modeling is using the "trial and error" strategy. A model 
is proposed and tested if it fits enough to the reality. If 
the proposed model does not fit enough to the reality, the 
proposed model and their associated parameters are 
modified iteratively until we achieve a model that char-
acterizes with sufficient fidelity the observations.  
2.1. Maximum Likelihood Factor Analysis (MLFA) 
One of the methods that provided a good degree of fidel-
ity modeling the behavior of the cytokine levels in 
plasma, and the several degrees of severity of malaria, 
has been the maximum likelihood factor analysis 
(MLFA) [3]. The MLFA method, computes the maxi-
mum likelihood estimation (MLE) of the factor loadings 
matrix 
€ 
Λ of the factor analysis model: 
 
€ 
x = Λ f + µ + e , (1)  
where the vector
€ 
x  contains the values of the diverse cy-
tokine observed values (d=10). 
€ 
Λ  is a constant matrix (d 
x m) of factor loadings (or mixing matrix) to be esti-
mated. 
€ 
f  is a vector (length m=number of factors) of 
independent and standardized common factors with dis-
tribution 
€ 
N 0,I( ) . 
€ 
µ is a constant vector of means, and 
€ 
e  
is the noise vector with distribution 
€ 
N 0,ψ( ) . The itera-
tive numerical algorithm to estimate 
€ 
Λ  and 
€ 
ψ  is de-
scribed in [4, 5]. 
When the sample covariance matrix is of full rank, 
the ML solution always exists because the likelihood 
function is bounded (the covariance matrix is of full rank 
when the number of observations is greater than the 
number of variables).  
2.2. MLFA in malaria cytokines analysis 
The MLFA (with two factors) has been applied the to the 
analysis of the datum contained in one of the most large 
study undertaken to date [6]. In this study, several cyto-
kines levels in plasma (IFN-γ, IL-2, IL-5, IL-6, IL-12, 
IL-4, TGF-β, TNF-α, IL-10, IL-1β) are related with sev-
eral degrees of malaria severity: endemic control (EC), 
ex cerebral malaria (Ex-CM), mild malaria (MM), severe 
noncerebral malaria (SM) and cerebral malaria (CM). 
Due to that we want to focus our analysis only on the 
most serious malaria degrees (CM, SM and MM) we 
have grouped the individuals belonging to the classes EC 
and Ex-CM, in a new class called no-malaria (NM).  
The results of MLFA, are shown graphically in Fig-
ure 1, where all the data has been transformed into the 
new 2D space (with the inverse matrix of the ML estima-
tion of factor loadings matrix: 
€ 
Λ−1) and the boundary 
between classes can be established with simple lines 
(Voronoi diagram). From this result we can observe that 
all the measured cytokines are sufficient, in the sense 
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that they are sufficient for clearly recognize the four 
classes of malaria severity that we are considering: NM, 
CM, SM and MM (there is no overlapping between 
classes in the new 2D transformed space). 
 
 
Figure 1. Results of MLFA, k-means clustering 
and the centroid and boundary for each class.  
If we consider the absolute value of the vectorial con-
tribution of each cytokine in the new transformed 2D 
space (see figure 2), we can observe that all measured 
cytokines are relevant (sorted by magnitude: IL-1β, IL-2, 
IL-12, IL-10, IFN-γ, TNF-α, TGF-β, IL-5, IL-6), with 
the exception of IL-4, which is quasi irrelevant com-
pared with other contributions (very similar results are 
obtained without considering IL-4). 
 Now, if we observe the direction of the vectorial 
contribution of each cytokine individually (column vec-
tors of 
€ 
Λ−1) in the new transformed 2D space (figure 2), 
we can observe that there are two differentiated groups 
of cytokines. The group 1 (G1) formed by: IL-12, IL-6, 
IFN-γ, IL-2 and IL-5, and the group 2 (G2) formed by: 
TGF-β,  TNF-α, IL-10 and IL-1β. 
Roughly speaking, in terms of malaria severity de-
gree, this means that: 
· An increase of one or several cytokines levels in-
cluded in the G1, and at the same time a similar in-
crease of G2 cytokines, we are evolving from a no 
malaria state (NM) to the severe malaria state (SM). 
· A predominance of the increase of one or several 
cytokines levels included in the G1 over G2 cytoki-
nes, we are evolving from a no malaria state (NM) 
to the mild malaria state (MM). 
· A predominance of the increase of one or several 
cytokines levels included in the G2 over G1 cytoki-
nes, we are evolving from a no malaria state (NM) 
to the cerebral malaria state (CM). 
· Within each cytokines group (G1 or G2) not all he 
cytokines have the same contribution in order to 
evolve to a determinate state. For example, in G1 
group, the IL-12 contribution is greater than IL-2 or 
IFN-γ in order to reach the MM state. Analogously 
in G2 group, the contribution of TGF-β or TNF-α is 
greater than IL-1β in order to reach the CM state.  
 
Figure 2. MLFA superposed to of the cytokines 
vectorial contribution in the new 2D space.  
As a result of MLFA, in the 2D new space, the fac-
tor-1 axis (abscises) measures the no-malaria/malaria 
degree (from negative for no malaria, to positive values 
for malaria), while the vertical axis measures the malaria 
severity degree: CM, SM and MM. (range values for fac-
tor-2 axis: (-∞, -0.7), [-0.7, 0.6], and (0.6, ∞) corre-
sponds to CM, SM and MM respectively).  
The main difference between our results, obtained 
with MLFA and the results obtained with LDA in [6], is 
the estimation of the contribution of each cytokine to the 
different degrees of malaria severity (for example, while 
in [6] show that TGF-β does not contribute to any ma-
laria state: SM, MM, CM, we observe that TGF-β is the 
most contributive cytokine to CM state).  
If we conclude that the measured cytokines (with the 
exception of IL-4) are sufficient to clearly discriminate 
between: NM, CM, SM and MM, which is the mecha-
nism that makes that a malaria infected inhabitant of en-
demic malaria zones, evolve to a SM or a CM in spite of 
to MM?  
3. ADAPTIVE IMMUNITY MODEL 
The response of the human immune system to the pres-
ence of different pathogens is mediated by the T helper 
cells (Th cells or naive CD4 + cells) [7]. 
The selective activation of different subsets of Th 
cells (Th1, Th2, Treg, Th17) is mainly controlled by the 
activation of the Th cells receptors, the cytokines and 
other co-stimulatory molecules. The cells of the different 
cellular lines: Th1, Th2, Th17 and Treg, are specialized 
in the production of some cytokines depending on the 
stimuli. 
3.1. A qualitative simplified model 
The details of this regulation system in humans is par-
tially known and based in mice models [8]. The model 
introduced in this section has the particularity to consider 
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the cytokines as state variables and consider four cellular 
lines: Th1, Th2, Treg and Th17. Considering the cytoki-
nes as the central point of the system, as state variables 
(fully observable), clarifies the role (stimuli or inhibitor) 
of each cytokine over the different cellular lines. Con-
sidering four cellular lines (rather than the classical 
Th1/Th2 used until now in malaria), we introduce two 
new freedom degrees, in order to interpret the results of 
previous section in terms of Th1/Th2/Treg/Th17 cellular 
activity (would be impossible to explain the results ob-
tained in section 2 only in terms of Th1/Th2 activity). 
The figure 3, shows the qualitative relations (pres-
ently known in humans) between cytokines, acting as 
stimuli or as inhibitor (through the corresponding tran-
scription factor), and each cellular line. Note that IL-12 
(canonical) is only supplied externally. While, in the 
regulatory system of the cellular lines, Th1, Th2 and 
Treg, the degree of similarity between humans and mice 
is very high, this is not the case of the cellular line Th17, 
where substantial differences have been observed [9-12]. 
In Th17 cellular line the stimulatory loop: IL-1β, IL-6, 
IL-23 (TGF-β, TNF-α) means that IL-1β is the neces-
sary cytokine for Th17 cells production stimulation, IL-6 
and IL-23 have co-stimulatory effects, but the maximum 
is obtained with a weighted combination of five cytoki-
nes: IL-1β, IL-6, IL-23, TGF-β and TNF-α (see [12]). 
RORC is the human ortholog of RORγt, the putative 
murine Th17 master regulatory transcription factor.  
 
 
Figure 3. Schematic representation of qualitative 
relations between cytokines (stimulation, inhibi-
tion loops and externally supplied), and transcrip-
tion factors, for each cellular line (Th1, Th2, Treg 
and Th17) in humans. 
The cytokines, are not only produced by Th1, Th2, 
Th17 or Treg cells, they are also produced for other cells 
type such as macrophages or dendritic cells. This model 
also includes a possible contribution of any cytokine ex-
ternally produced. In malaria, it has been observed in vi-
tro that, in response to the Plasmodium, dendritic cells 
synthesize IL-12 and IL-6 and the macrophages secrete 
TNF-α IL-1, IL-6 and IL-8 [13, 14].  
3.2. Relation between malaria cytokine analysis and 
the simplified model 
Based on the data analysis of section 2 and its corre-
spondence with the simplified model of the last section, 
we could say that: 
· A high level of IL-6 may play a decisive role in a 
favorable resolution of malaria because they mini-
mize the production/activation of anti-inflammatory 
cytokine TGF-β and IL-10 acting on the transcrip-
tion factor Foxp3 (Forkhead Transcription Factor 
Winger Box3) [7, 15]. 
· With a low levels of TGF-β and IL-10 and given its 
negative cross-correlation with IL-12, a higher level 
of IL-12 would be expected, and as consequence a 
higher levels of IFN-γ and IL-2 (Th1).  
· If the levels of IL-12 and IFN-γ are high, it means 
that a lower activity of the Th17 cellular line (IFN-γ 
and IL-12 inhibits Th17 activity acting on RORC 
transcription factor) and lower levels of IL-1β, TNF-
α would be expected.  
In conclusion, it means that the initial level of IL-6 
can be determinant, in the role of steer the response of 
immunitary system towards a major G1 cytokines (IL-
12, IL-6, IFN-γ, IL-2 and IL-5) production, in detriment 
of the G2 cytokine (TGF-β,  TNF-α, IL-10 and IL-1β) 
production (and viceversa).  
4. DISCUSSION 
4.1. The hypothesis of the key role of the initial levels 
of IL-6 in malaria 
Therefore in malaria, the IL-6 can be the “key cytokine” 
capable to bias the immunological system response to-
wards a predominance of Th1 and Th2 cellular lines, 
over Treg and Th17. In the case of the malaria, the prob-
lem is that, the levels of IL-6 should be high before the 
parasites abandon the liver in order to inhibit the charac-
teristic TGF-β activation and upregulation of Foxp3. It 
has been observed in humans, that the levels of the IFN-
γ, IL-12, IL-10, TNF-α and IL-4 in plasma increase 4 or 
5 days after the TGF-β burst [16].  
It seems that an initial high level of IL-6 (and proba-
bly extended in time), should be a necessary initial con-
dition to meet previously the parasite abandons the liver. 
Similarly we might think that people with symptoms of 
chronic inflammation, that clearly implies a high level of 
IL-6, could be examples of this bias in their immune sys-
tem response. The sickle cell disease (SCD) and G6PD 
deficiency are examples of chronic inflammation and the 
patients with this disease can double the levels of IL-1 
and IL-6 in respect control persons [17, 18]. Otherwise, 
the sickle cell disease and the G6PD deficiency, have 
been diseases traditionally associated to some degree of 
protection against severe malaria [19].  
4.2. Signs of evidence of our hypotheses 
Testing the hypothesized key role of the initial high lev-
els of IL-6 in malaria infection is not a simple task, at 
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least "in vivo” and in humans. But, we believe that there 
are some research works that could help make our hy-
pothesis more likely. 
Interethnic studies made in Mali and Burkina Faso on 
the susceptibility to malaria in areas where it is hyper-
endemic, shows that the Fulani are less susceptible than 
their own neighbors of other ethnic groups. In a recent 
work [20] it was found that their immunity can be con-
ferred by their genetic profile where the Fulani express 
higher amounts of RNA of some genes related to the Th1 
and Th2, and a lower expression of the gene FOXP3 and 
CTLA4 compared with its neighbors, the Mossi ethnic 
group. Both FOXP3 as CTLA4 are directly involved in 
the activity regulation of Treg cell line and suggests that 
a functional deficit of Treg cells could be related to the 
lower susceptibility to malaria in this ethnic group. 
5. CONCLUSION 
To confirm the hypothesis presented here, on the role of 
an initial high level of IL-6, in the favorable outcome in 
a malaria infection, we would contributed to clarify 
some of the mechanisms by which the Plasmodium in-
teracts with the human immune system. 
Otherwise, all this work is based on an extended 
study of cytokines in malaria, and need to be properly 
weighted, because the samples were obtained in a very 
specific geographical area of India, and some of our re-
sults, observations and conclusions may not be valid, re-
producible or extrapolated to other parts of the planet.  
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